TOKYO, May 13 (Pulse News Wire) – Susmed,inc. (4263.T) announced today that its insomnia treatment app, Medcle, received approval for insurance coverage from the Central Social Insurance Medical Council.
The app, which was submitted for insurance application on September 4, 2025, is set to launch on June 1, 2026. Medcle offers a non-pharmacological alternative to traditional sleep medication treatments, addressing the limitations associated with drug therapies such as side effects and dependency issues.
The app provides cognitive behavioral therapy principles through a nine-week program aimed at reducing insomnia symptoms without pharmaceutical intervention. It is designed to support patients who cannot tolerate existing treatments due to safety concerns or insufficient efficacy.
The reimbursement price for Medcle is ¥24,100 per session, and the company expects to disclose the impact on its fiscal year 2026 performance once sales trends are clearer.
🟡 Confidence: Standard AI-translated content.